全文获取类型
收费全文 | 1437篇 |
免费 | 108篇 |
国内免费 | 16篇 |
专业分类
耳鼻咽喉 | 15篇 |
儿科学 | 53篇 |
妇产科学 | 72篇 |
基础医学 | 136篇 |
口腔科学 | 15篇 |
临床医学 | 103篇 |
内科学 | 246篇 |
皮肤病学 | 10篇 |
神经病学 | 102篇 |
特种医学 | 239篇 |
外科学 | 86篇 |
综合类 | 33篇 |
预防医学 | 71篇 |
眼科学 | 7篇 |
药学 | 146篇 |
中国医学 | 1篇 |
肿瘤学 | 226篇 |
出版年
2021年 | 14篇 |
2020年 | 21篇 |
2019年 | 10篇 |
2018年 | 19篇 |
2017年 | 16篇 |
2016年 | 20篇 |
2015年 | 22篇 |
2014年 | 25篇 |
2013年 | 28篇 |
2012年 | 37篇 |
2011年 | 47篇 |
2010年 | 36篇 |
2009年 | 40篇 |
2008年 | 34篇 |
2007年 | 53篇 |
2006年 | 42篇 |
2005年 | 41篇 |
2004年 | 40篇 |
2003年 | 53篇 |
2002年 | 39篇 |
2001年 | 50篇 |
2000年 | 37篇 |
1999年 | 41篇 |
1998年 | 53篇 |
1997年 | 57篇 |
1996年 | 47篇 |
1995年 | 28篇 |
1994年 | 48篇 |
1993年 | 30篇 |
1992年 | 36篇 |
1991年 | 40篇 |
1990年 | 43篇 |
1989年 | 61篇 |
1988年 | 39篇 |
1987年 | 37篇 |
1986年 | 42篇 |
1985年 | 27篇 |
1984年 | 33篇 |
1983年 | 21篇 |
1982年 | 18篇 |
1981年 | 30篇 |
1980年 | 15篇 |
1979年 | 7篇 |
1978年 | 11篇 |
1977年 | 14篇 |
1976年 | 14篇 |
1975年 | 12篇 |
1974年 | 7篇 |
1973年 | 4篇 |
1971年 | 4篇 |
排序方式: 共有1561条查询结果,搜索用时 15 毫秒
1.
M Engelhardt P Bast N Jeblink W Lauer A Popovic H Eufinger M Scholz A Christmann A Harders K Radermacher K Schmieder 《Minimally invasive neurosurgery》2006,49(2):98-103
This study was performed to evaluate the surgical strategy in patients with calvarial tumours, in order to design and modify a robot-assisted trepanation system. A total of 75 patients underwent craniectomy for the treatment of calvarial tumours during the 10-year period from 1993 to 2002. The patients' complaints, the size, location and histology of the tumour, and the various cranioplasty techniques used were analysed retrospectively. In a second procedure several craniectomies at typical locations according to the study's results were performed in a laboratory setting using a hexapod robotic tool, constructed at the Helmholtz-Institute, RWTH Aachen University, and plastic model heads. The workflow was documented and the reproducibility and the accuracy of the procedure were registered. A total of 83 surgical procedures were performed on 75 patients. The majority (87 %) of lesions treated surgically were located in the frontal, temporal and anterior parts of the parietal region. Histological examination revealed benign lesions in 66 % of the patients and dural involvement in 46 %. According to these results craniectomies were performed using the robotic system. Mean positioning accuracy of the robotic system while milling was 0.24 mm, with a standard deviation of 0.04 mm, and maximum error under 1 mm. Craniectomies leaving a 1-mm layer of the tabula interna intact to ensure a healthy dura were performed in several regions successfully. The majority of calvarial tumours, requiring surgical treatment in our patients, were located in cosmetically relevant areas in which drilling can be carried out with the robotic trepanation system. Consequently, the surgical approach had to be planned carefully in order to achieve a good cosmetic outcome. 相似文献
2.
3.
4.
Occurrence of the t(2;5)(p23;q35) in non-Hodgkin's lymphoma 总被引:9,自引:3,他引:6
Weisenburger DD; Gordon BG; Vose JM; Bast MA; Chan WC; Greiner TC; Anderson JR; Sanger WG 《Blood》1996,87(9):3860-3868
Primary CD30(Ki-1)-positive anaplastic large-cell lymphoma (ALCL) is considered by some to be a distinct clinicopathologic entity associated with the t(2;5) (p23;q35). However, the specificity of t(2;5) for ALCL has not been carefully studied. Therefore, we performed a detailed analysis of all cases of ALCL with abnormal cytogenetics results in the Nebraska Lymphoma Study Group registry, as well as all other cases of non-Hodgkin's lymphoma with t(2;5) in the registry. We found the t(2;5) in only five of 10 cases of ALCL, four of whom were young patients. However, we also found the t(2;5) in 11 other cases of nonanaplastic lymphoma, including eight children with typical peripheral T-cell lymphomas of various types. The t(2;5) was also found in three older adults with B-cell lymphomas of various types. Thus, the t(2;5) was not specific for CD30+ ALCL. However, t(2;5) may define a clinicopathologic entity in children and young adults characterized by variable morphologies with a T-cell or indeterminate phenotype, CD30-positivity, nodal disease with frequent extranodal involvement, advanced stage, and an excellent response to therapy, including bone marrow transplantation for relapsed disease. The clinical relevance of the t(2;5) in older patients requires further study. 相似文献
5.
6.
BACKGROUND. Although the ascites of patients with ovarian cancer has been reported to contain immunosuppressive factors, the identity and source of this activity has not been determined. Previously, the authors showed that conditioned media from two of four epithelial ovarian cancer cell lines inhibits proliferation of mitogen-stimulated human lymphocytes. The physical characteristics of the inhibitory substance are unlike those of peptide growth factors but closely resemble those of fibronectin. METHODS AND RESULTS. In the current study, it was found that the two ovarian cancer cell lines that produce the inhibitory substance have more fibronectin on the cell surface and secrete significantly more immunoreactive fibronectin into their culture media than the other two ovarian cancer cell lines. In addition, the immunosuppressive activity was bound to a gelatin-Sepharose affinity column, known to bind fibronectin. Finally, in ascites from 20 patients with advanced epithelial ovarian cancer, fibronectin levels correlated with the ability to inhibit proliferation of lectin-stimulated lymphocytes (P < 0.001). CONCLUSIONS. Fibronectin is produced by some ovarian cancer cell lines and acts to inhibit proliferation of mitogen-stimulated lymphocytes. Additional studies are needed to clarify the role of fibronectin in ovarian cancer. 相似文献
7.
8.
9.
10.
Determination of the growth fraction in monoclonal gammopathy with the monoclonal antibody Ki-67 总被引:3,自引:0,他引:3
Henk M. Lokhorst Saskia E. Boom Wim Terpstra Paul Roholl Johannes Gerdes Bert J. E. G. Bast 《British journal of haematology》1988,69(4):477-481
The monoclonal antibody Ki-67 reacts with a nuclear antigen that is present only in proliferating cells. The proportion of Ki-67 positive cells may therefore serve as a reliable measurement for the growth fraction in normal and neoplasmic cell populations. We have tested the significance of the MoAb Ki-67 in the classification of monoclonal gammopathy and compared the results with the plasma cell labelling index. In benign monoclonal gammopathy the percentage of Ki-67 positive plasma cells (median 1.6%) was significantly lower than in untreated multiple myeloma (median 9.6). Among the patients with more than 10% Ki-67 positive plasma cells there were some very short survivors. The largest growth fractions (median 41.8%) were found in patients with relapsing multiple myeloma indicating here a different growth pattern more resembling the high-grade lymphomas. A linear correlation between the proportion of Ki-67 positive plasma cells and the labelling index was not found. Determination of the plasma cell growth fraction with the monoclonal antibody Ki-67 in monoclonal gammopathy may help to discriminate benign monoclonal gammopathy from multiple myeloma and will probably identify a subgroup of multiple myeloma patients with a poor prognosis, including those with relapsing multiple myeloma. 相似文献